SARS-CoV-2 Omicron Spike RBD and Antibody Set

<strong>SARS-CoV-2 Omicron Spike RBD and Specific Antibody Set</strong>_x000D_ <strong>Catalog number:</strong> B2010596_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 2 x 100 ug_x000D_ <strong>Molecular Weight or Concentration:</strong> na_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular component of various serological and antigenic assays for SARS-CoV-2 and its variants_x000D_ <strong>Storage:</strong> -20C_x000D_ <strong>Keywords:</strong> SARS-CoV-2 Spike Antibody, Omicron Antibody, SARS-CoV-2 B.1.1.529, Omicron RBD, Omicron Spike_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <a href="https://moleculardepot.com/wp-content/uploads/2022/03/MKT-010-SARS-CoV-2-Brochure-Rev-A.pdf">Download SARS-CoV-2 Brochure</a>_x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Criscuolo E, Diotti RA, Ferrarese R, Alippi C, Viscardi G, Signorelli C,_x000D_ Mancini N, Clementi M, Clementi N. Fast inactivation of SARS-CoV-2 by UV-C and_x000D_ ozone exposure on different materials. Emerg Microbes Infect. 2021_x000D_ Dec;10(1):206-210._x000D_ _x000D_ 2: Kannan SR, Spratt AN, Quinn TP, Heng X, Lorson CL, Sönnerborg A, Byrareddy_x000D_ SN, Singh K. Infectivity of SARS-CoV-2: there Is Something More than D614G? J_x000D_ Neuroimmune Pharmacol. 2020 Dec;15(4):574-577._x000D_ _x000D_ 3: Zhou Y, Pei F, Ji M, Wang L, Zhao H, Li H, Yang W, Wang Q, Zhao Q, Wang Y._x000D_ Sensitivity evaluation of 2019 novel coronavirus (SARS-CoV-2) RT-PCR detection_x000D_ kits and strategy to reduce false negative. PLoS One. 2020 Nov_x000D_ 18;15(11):e0241469._x000D_ _x000D_ 4: Beck ET, Paar W, Fojut L, Serwe J, Jahnke RR. Comparison of the Quidel Sofia_x000D_ SARS FIA Test to the Hologic Aptima SARS-CoV-2 TMA Test for Diagnosis of_x000D_ COVID-19 in Symptomatic Outpatients. J Clin Microbiol. 2021 Jan_x000D_ 21;59(2):e02727-20._x000D_ _x000D_ 5: Ginsburg I, Fibach E. Polycations and polyanions in SARS-CoV-2 infection. Med_x000D_ Hypotheses. 2021 Jan;146:110470._x000D_ _x000D_ 6: Luo Y, Yu F, Zhou M, Liu Y, Xia B, Zhang X, Liu J, Zhang J, Du Y, Li R, Wu L,_x000D_ Zhang X, Pan T, Guo D, Peng T, Zhang H. Engineering a Reliable and Convenient_x000D_ SARS-CoV-2 Replicon System for Analysis of Viral RNA Synthesis and Screening of_x000D_ Antiviral Inhibitors. mBio. 2021 Jan 19;12(1):e02754-20._x000D_ _x000D_ 7: Littler DR, MacLachlan BJ, Watson GM, Vivian JP, Gully BS. A pocket guide on_x000D_ how to structure SARS-CoV-2 drugs and therapies. Biochem Soc Trans. 2020 Dec_x000D_ 18;48(6):2625-2641._x000D_ _x000D_ 8: Antonelli G, Stefani S, Pistello M. SARS-CoV-2 diagnostics: Some reflections_x000D_ on current assays. Diagn Microbiol Infect Dis. 2021 Feb;99(2):115237._x000D_ _x000D_ 9: Wurtz N, Penant G, Jardot P, Duclos N, La Scola B. Culture of SARS-CoV-2 in a_x000D_ panel of laboratory cell lines, permissivity, and differences in growth profile._x000D_ Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):477-484._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/33049366/">10: Yano H, Nakano R, Suzuki Y, Nakano A, Kasahara K, Hosoi H. Inactivation of_x000D_ severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by gaseous ozone_x000D_ treatment. J Hosp Infect. 2020 Dec;106(4):837-838. </a>_x000D_ _x000D_ <strong>Products Related to SARS-CoV-2 Omicron Spike RBD and Specific Antibody Set</strong><a href="https://moleculardepot.com/product-category/Proteins/">: Proteins</a>